Detecçäo de mRNAs quiméricos BCR/ABL em pacientes portadores de leucemia mielóide crônica, leucemia linfóide aguda/mielóide aguda pela reaçäo de polimerizaçäo em cadeia (PCR)

Gushiken, Tsieko; Pardini, Maria Inês M. C; Hokama, Paula O. M; Colturato, Vergílio A. R; Machado, Paulo E. A.
J. bras. med ; 72(1/2): 41-2, 45-6, 48, 50, jan.-fev. 1997. ilus, tab
Artículo en Portugués | LILACS | ID: lil-191362

Documentos relacionados

  1. Highly precise breakpoint detection of chromosome balanced translocation in chronic myelogenous leukaemia: Case series.
  2. Establishment of the Myeloid TBX-Code Reveals Aberrant Expression of T-Box Gene TBX1 in Chronic Myeloid Leukemia.
  3. Measurable residual disease in chronic myeloid leukemia.
  4. FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.
  5. Genetic Landscape of Chronic Myeloid Leukemia and a Novel Targeted Drug for Overcoming Resistance.
  6. Targeted disruption of the <i>BCR-ABL</i> fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells.
  7. Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3- and 6-month time points.
  8. Best Practices in Chronic Myeloid Leukemia Monitoring and Management.
  9. New patterns of genetic instability in chronic myeloid leukemia: interesting, but not ready for clinical use.
  10. Single cells tell multiple tales in CML.